More importantly, serum ALT levels were significantly higher in NASH subjects (median 86 IU/L, IQR 55 IU/L–121 IU/L) compared to non-NASH subjects (median 61 IU/L, IQR 44 IU/L–93 IU/L, p<0.05). This evidence concerns the gene GPT and metabolic dysfunction-associated steatohepatitis.